Form 8-K - Current report:
SEC Accession No. 0001104659-20-102011
Filing Date
2020-09-03
Accepted
2020-09-03 06:30:21
Documents
4
Period of Report
2020-09-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2029952d1_8k.htm 8-K 21886
2 EXHIBIT 5.1 tm2029952d1_ex5-1.htm EX-5.1 10555
3 EXHIBIT 10.1 tm2029952d1_ex10-1.htm EX-10.1 226020
4 GRAPHIC tm2029952d1_ex5-1img001.jpg GRAPHIC 11395
  Complete submission text file 0001104659-20-102011.txt   275414
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 201158209
SIC: 2834 Pharmaceutical Preparations